Veracyte Cost Of Revenue from 2010 to 2024
| VCYT Stock | USD 42.89 0.05 0.12% |
Cost Of Revenue | First Reported 2011-12-31 | Previous Quarter 38.6 M | Current Value 36.9 M | Quarterly Volatility 10.6 M |
Check Veracyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Veracyte's main balance sheet or income statement drivers, such as Depreciation And Amortization of 28.5 M, Interest Expense of 14.2 K or Selling General Administrative of 165.5 M, as well as many indicators such as Price To Sales Ratio of 5.26, Dividend Yield of 0.0 or PTB Ratio of 1.82. Veracyte financial statements analysis is a perfect complement when working with Veracyte Valuation or Volatility modules.
Veracyte | Cost Of Revenue |
Latest Veracyte's Cost Of Revenue Growth Pattern
Below is the plot of the Cost Of Revenue of Veracyte over the last few years. Cost of Revenue is found on Veracyte income statement and represents the costs associated with goods and services Veracyte provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is Veracyte's Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Veracyte's overall financial position and show how it may be relating to other accounts over time.
| Cost Of Revenue | 10 Years Trend |
|
Cost Of Revenue |
| Timeline |
Veracyte Cost Of Revenue Regression Statistics
| Arithmetic Mean | 42,419,343 | |
| Geometric Mean | 25,219,867 | |
| Coefficient Of Variation | 93.93 | |
| Mean Deviation | 31,700,770 | |
| Median | 28,195,000 | |
| Standard Deviation | 39,843,731 | |
| Sample Variance | 1587.5T | |
| Range | 115.6M | |
| R-Value | 0.92 | |
| Mean Square Error | 258.1T | |
| R-Squared | 0.85 | |
| Slope | 8,209,311 | |
| Total Sum of Squares | 22225.3T |
Veracyte Cost Of Revenue History
About Veracyte Financial Statements
Veracyte shareholders use historical fundamental indicators, such as Cost Of Revenue, to determine how well the company is positioned to perform in the future. Although Veracyte investors may analyze each financial statement separately, they are all interrelated. The changes in Veracyte's assets and liabilities, for example, are also reflected in the revenues and expenses on on Veracyte's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Cost Of Revenue | 112.9 M | 118.5 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Veracyte Stock Analysis
When running Veracyte's price analysis, check to measure Veracyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veracyte is operating at the current time. Most of Veracyte's value examination focuses on studying past and present price action to predict the probability of Veracyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veracyte's price. Additionally, you may evaluate how the addition of Veracyte to your portfolios can decrease your overall portfolio volatility.